BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sampaio-maia B, Simões-silva L, Pestana M, Araujo R, Soares-silva I. The Role of the Gut Microbiome on Chronic Kidney Disease. Elsevier; 2016. pp. 65-94. [DOI: 10.1016/bs.aambs.2016.06.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Ouyang S, Xie Y, Gong Z, Du J. Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med 2020;132:495-505. [PMID: 32241215 DOI: 10.1080/00325481.2020.1744335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
2 Hu S, Wang J, Wang J, Li S, Jiang W, Liu Y. Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice. Journal of Functional Foods 2017;31:123-30. [DOI: 10.1016/j.jff.2017.01.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
3 Lohia S, Vlahou A, Zoidakis J. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective. Toxins 2022;14:176. [DOI: 10.3390/toxins14030176] [Reference Citation Analysis]
4 Maiwall R, Gupta M. Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation. Transl Gastroenterol Hepatol 2020;5:18. [PMID: 32258522 DOI: 10.21037/tgh.2019.10.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Panickar KS, Jewell DE. The Benefit of Anti-Inflammatory and Renal-Protective Dietary Ingredients on the Biological Processes of Aging in the Kidney. Biology (Basel) 2018;7:E45. [PMID: 30274250 DOI: 10.3390/biology7040045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Sampaio-Maia B, Caldas IM, Pereira ML, Pérez-Mongiovi D, Araujo R. The Oral Microbiome in Health and Its Implication in Oral and Systemic Diseases. Adv Appl Microbiol 2016;97:171-210. [PMID: 27926431 DOI: 10.1016/bs.aambs.2016.08.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 11.5] [Reference Citation Analysis]
7 Merino-Ribas A, Araujo R, Bancu I, Graterol F, Vergara A, Noguera-Julian M, Paredes R, Bonal J, Sampaio-Maia B. Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study. Int Urol Nephrol 2021. [PMID: 34923600 DOI: 10.1007/s11255-021-03091-3] [Reference Citation Analysis]
8 Szeto CC, McIntyre CW, Li PK. Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD. J Am Soc Nephrol 2018;29:1601-8. [PMID: 29666156 DOI: 10.1681/ASN.2018010068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, Zhao YY. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med 2019;17:5. [PMID: 30602367 DOI: 10.1186/s12967-018-1756-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 28.7] [Reference Citation Analysis]
10 Yang L, Wang L, Wang X, Xian CJ, Lu H. A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis. Int J Mol Sci 2016;17:E2126. [PMID: 27999312 DOI: 10.3390/ijms17122126] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
11 Simões-silva L, Araujo R, Pestana M, Soares-silva I, Sampaio-maia B. The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis. Pharmacological Research 2018;130:143-51. [DOI: 10.1016/j.phrs.2018.02.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
12 Liu L, Pang XL, Shang WJ, Xie HC, Wang JX, Feng GW. Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1. Mol Med 2018;24:49. [PMID: 30241461 DOI: 10.1186/s10020-018-0045-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
13 Caggiano G, Cosola C, Di Leo V, Gesualdo M, Gesualdo L. Microbiome modulation to correct uremic toxins and to preserve kidney functions. Curr Opin Nephrol Hypertens 2020;29:49-56. [PMID: 31725010 DOI: 10.1097/MNH.0000000000000565] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
14 Joyce T, Chirino YI, Natalia M, Jose P. Renal damage in the metabolic syndrome (MetSx): Disorders implicated. European Journal of Pharmacology 2018;818:554-68. [DOI: 10.1016/j.ejphar.2017.11.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Targher G, Byrne CD. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol. 2017;13:297-310. [PMID: 28218263 DOI: 10.1038/nrneph.2017.16] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 23.0] [Reference Citation Analysis]
16 Di Iorio BR, Rocchetti MT, De Angelis M, Cosola C, Marzocco S, Di Micco L, di Bari I, Accetturo M, Vacca M, Gobbetti M, Di Iorio M, Bellasi A, Gesualdo L. Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study). J Clin Med 2019;8:E1424. [PMID: 31510015 DOI: 10.3390/jcm8091424] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
17 Gabarre P, Loens C, Tamzali Y, Barrou B, Jaisser F, Tourret J. Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences. Am J Transplant 2021. [PMID: 34510717 DOI: 10.1111/ajt.16836] [Reference Citation Analysis]
18 Choi E, Yang J, Ji GE, Park MS, Seong Y, Oh SW, Kim MG, Cho WY, Jo SK. The effect of probiotic supplementation on systemic inflammation in dialysis patients. Kidney Res Clin Pract 2021. [PMID: 34974660 DOI: 10.23876/j.krcp.21.014] [Reference Citation Analysis]
19 Lai S, Molfino A, Testorio M, Perrotta AM, Currado A, Pintus G, Pietrucci D, Unida V, La Rocca D, Biocca S, Desideri A. Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease. Nutrients 2019;11:E3006. [PMID: 31818021 DOI: 10.3390/nu11123006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
20 Adda-Rezig H, Carron C, Pais de Barros JP, Choubley H, Charron É, Rérole AL, Laheurte C, Louvat P, Gaiffe É, Simula-Faivre D, Deckert V, Lagrost L, Saas P, Ducloux D, Bamoulid J. New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response. Front Immunol 2021;12:658404. [PMID: 34163471 DOI: 10.3389/fimmu.2021.658404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kang SM, Jung HI, Kim BI. Susceptibility of oral bacteria to antibacterial photodynamic therapy. J Oral Microbiol 2019;11:1644111. [PMID: 31448062 DOI: 10.1080/20002297.2019.1644111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Bhardwaj N, Kumar B, Agrawal K, Verma P. Current perspective on production and applications of microbial cellulases: a review. Bioresour Bioprocess 2021;8. [DOI: 10.1186/s40643-021-00447-6] [Reference Citation Analysis]
23 Garcia A, Macedo MH, Azevedo MJ, Pestana M, Sarmento B, Sampaio-maia B. Effect of uremic state in intestine through a co-culture in vitro intestinal epithelial model. International Journal of Pharmaceutics 2020;584:119450. [DOI: 10.1016/j.ijpharm.2020.119450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens Res 2019;42:123-40. [PMID: 30504819 DOI: 10.1038/s41440-018-0144-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
25 La Carpia F, Wojczyk BS, Annavajhala MK, Rebbaa A, Culp-Hill R, D'Alessandro A, Freedberg DE, Uhlemann AC, Hod EA. Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron. NPJ Biofilms Microbiomes 2019;5:26. [PMID: 31583109 DOI: 10.1038/s41522-019-0097-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kouidhi S, Souai N, Alhujaily M, Zidi O, Kochbati A, Redissi A, Belali TM, Kossai IE, El Manaa J, Cherif A, Mnif W, Mosbah A. Multi-Solvent Extraction Procedure for the Pioneer Fecal Metabolomic Analysis-Identification of Potential Biomarkers in Stable Kidney Transplant Patients. Diagnostics (Basel) 2021;11:962. [PMID: 34073647 DOI: 10.3390/diagnostics11060962] [Reference Citation Analysis]
27 He LX, Abdolmaleky HM, Yin S, Wang Y, Zhou JR. Dietary Fermented Soy Extract and Oligo-Lactic Acid Alleviate Chronic Kidney Disease in Mice via Inhibition of Inflammation and Modulation of Gut Microbiota. Nutrients 2020;12:E2376. [PMID: 32784477 DOI: 10.3390/nu12082376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Francavilla R, Cristofori F, Vacca M, Barone M, De Angelis M. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease. Expert Rev Gastroenterol Hepatol 2020;14:323-33. [PMID: 32216476 DOI: 10.1080/17474124.2020.1745630] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
29 Lecamwasam A, Ekinci EI, Saffery R, Dwyer KM. Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome. Biomedicines 2020;8:E341. [PMID: 32927866 DOI: 10.3390/biomedicines8090341] [Reference Citation Analysis]
30 Xu X, Wang H, Guo D, Man X, Liu J, Li J, Luo C, Zhang M, Zhen L, Liu X. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy. Ren Fail 2021;43:1063-75. [PMID: 34187292 DOI: 10.1080/0886022X.2021.1944875] [Reference Citation Analysis]
31 Sircana A, De Michieli F, Parente R, Framarin L, Leone N, Berrutti M, Paschetta E, Bongiovanni D, Musso G. Gut microbiota, hypertension and chronic kidney disease: Recent advances. Pharmacol Res 2019;144:390-408. [PMID: 29378252 DOI: 10.1016/j.phrs.2018.01.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
32 Swarte JC, Douwes RM, Hu S, Vich Vila A, Eisenga MF, van Londen M, Gomes-Neto AW, Weersma RK, Harmsen HJM, Bakker SJL. Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients. J Clin Med. 2020;9. [PMID: 32024079 DOI: 10.3390/jcm9020386] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
33 Lakshmanan AP, Al Za'abi M, Ali BH, Terranegra A. The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease. Biomed Pharmacother 2021;133:110992. [PMID: 33202283 DOI: 10.1016/j.biopha.2020.110992] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Lauriero G, Abbad L, Vacca M, Celano G, Chemouny JM, Calasso M, Berthelot L, Gesualdo L, De Angelis M, Monteiro RC. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy. Front Immunol 2021;12:694787. [PMID: 34712223 DOI: 10.3389/fimmu.2021.694787] [Reference Citation Analysis]
35 Salvadori M, Tsalouchos A. Microbiota, renal disease and renal transplantation. World J Transplant 2021; 11(3): 16-36 [PMID: 33816144 DOI: 10.5500/wjt.v11.i3.16] [Reference Citation Analysis]
36 Simões-Silva L, Araujo R, Pestana M, Soares-Silva I, Sampaio-Maia B. Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy. Microorganisms 2020;8:E173. [PMID: 31991821 DOI: 10.3390/microorganisms8020173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Huang H, Li K, Lee Y, Chen M. Preventive Effects of Lactobacillus Mixture against Chronic Kidney Disease Progression through Enhancement of Beneficial Bacteria and Downregulation of Gut-Derived Uremic Toxins. J Agric Food Chem 2021;69:7353-66. [PMID: 34170659 DOI: 10.1021/acs.jafc.1c01547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, Song J, Zhang J, Peng H. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses. Front Cell Infect Microbiol 2021;11:579386. [PMID: 33834002 DOI: 10.3389/fcimb.2021.579386] [Reference Citation Analysis]